Indian online healthcare service MediBuddy, which offers doctor video calls and more, raises a $125M Series C led by Quadria Capital and Lightrock India
Deepsekhar Choudhury / Business Standard :
Context & Ripple Effects
MediBuddy's $125M Series C is the largest telehealth check in this coverage since Shanghai's MediTrust Health raised $308M for online payments and pharmacy, and it lands five years after Practo's Tencent-led $55M Series D set the earlier benchmark for Indian healthcare platforms. The round signals that India's doctor-video-call market has moved from proving demand to funding consolidation.
First-order effects
- Quadria Capital and Lightrock India now hold a large position in one of India's two scaled consultation platforms, giving MediBuddy the balance sheet to outspend Practo on patient acquisition and service expansion.
Second-order effects
- Practo faces a rival with fresh Series C-scale capital, while younger entrants like Bengaluru's Mojocare, which raised a $20.6M Series A months later, must either raise bigger rounds or differentiate on niche services rather than head-on consultation volume.
Third-order effects
- If the pattern holds, Asian telehealth consolidates into full-stack platforms that bundle consultations with pharmacy and payment rails — the structure MediTrust built in China — leaving point-solution apps as acquisition targets rather than standalone winners.
The trend: Telemedicine funding in Asia is concentrating into fewer, larger rounds for full-stack platforms, widening the gap between scaled leaders and early-stage challengers.